Home

Anfällig für Genau Aufheben psa 0.03 Flackern Toxizität Gewähren

Biochemical recurrence after radical prostatectomy according to nadir  prostate specific antigen value | PLOS ONE
Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value | PLOS ONE

Cancers | Free Full-Text | Characteristics of PSA Bounce after Radiotherapy  for Prostate Cancer: A Meta-Analysis
Cancers | Free Full-Text | Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis

a) Correlation between tumor volume and PSA (Spearman correlation... |  Download Scientific Diagram
a) Correlation between tumor volume and PSA (Spearman correlation... | Download Scientific Diagram

Prostate specific antigen for early detection of prostate cancer:  longitudinal study | The BMJ
Prostate specific antigen for early detection of prostate cancer: longitudinal study | The BMJ

When should the patient and doctor consider salvage radiation therapy? |  THE "NEW" PROSTATE CANCER INFOLINK
When should the patient and doctor consider salvage radiation therapy? | THE "NEW" PROSTATE CANCER INFOLINK

Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in  Predicting Long-Term Biochemical Recurrence-Free Survival in Men after  Radical Prostatectomy? | Journal of Urology
Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy? | Journal of Urology

Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA  Testing to Identify High Risk Prostate Cancer on Biopsy | PLOS ONE
Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy | PLOS ONE

Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With  Outcomes of Long-term Antiandrogen Therapy in
Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in

SciELO - Brasil - Biochemical recurrence after radical prostatectomy: is  the disease or the surgeon to blame? Biochemical recurrence after radical  prostatectomy: is the disease or the surgeon to blame?
SciELO - Brasil - Biochemical recurrence after radical prostatectomy: is the disease or the surgeon to blame? Biochemical recurrence after radical prostatectomy: is the disease or the surgeon to blame?

Survival analysis demonstrating association between age, PSA, cT, GS... |  Download Table
Survival analysis demonstrating association between age, PSA, cT, GS... | Download Table

Systematic review and meta-analysis of the diagnostic accuracy of  prostate-specific antigen (PSA) for the detection of prostate cancer in  symptomatic patients | BMC Medicine | Full Text
Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients | BMC Medicine | Full Text

Prostate-specific antigen (PSA) bounce following salvage radiotherapy to  the prostate bed in a patient with prostate cancer post-prostatectomy |  SpringerLink
Prostate-specific antigen (PSA) bounce following salvage radiotherapy to the prostate bed in a patient with prostate cancer post-prostatectomy | SpringerLink

KoreaMed Synapse
KoreaMed Synapse

Cutoff value of time to prostate-specific antigen nadir is inversely  correlated with disease progression in advanced prostate cancer in:  Endocrine-Related Cancer Volume 19 Issue 5 (2012)
Cutoff value of time to prostate-specific antigen nadir is inversely correlated with disease progression in advanced prostate cancer in: Endocrine-Related Cancer Volume 19 Issue 5 (2012)

Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is  Not Associated with the Development of Detectable Postoperative Serum  Prostate Specific Antigen | Journal of Urology
Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen | Journal of Urology

Primary Care of the Prostate Cancer Survivor | AAFP
Primary Care of the Prostate Cancer Survivor | AAFP

fares of changes in PSA (ng/ml/yr) and PSA doubling times (yr)for... |  Download Table
fares of changes in PSA (ng/ml/yr) and PSA doubling times (yr)for... | Download Table

PDF] The Effect of Cystoscopy on PSA Levels in Patients with Urologic  Diseases | Semantic Scholar
PDF] The Effect of Cystoscopy on PSA Levels in Patients with Urologic Diseases | Semantic Scholar

New Research Shows PSMA PET/CT Imaging Changes Management for Close to 50%  of Prostate Cancer Patients | Imaging Technology News
New Research Shows PSMA PET/CT Imaging Changes Management for Close to 50% of Prostate Cancer Patients | Imaging Technology News

Low detectable PSA after prostatectomy – watch or treat? | THE "NEW"  PROSTATE CANCER INFOLINK
Low detectable PSA after prostatectomy – watch or treat? | THE "NEW" PROSTATE CANCER INFOLINK